Jul 282020
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– ITALY, Milan – Enthera Pharmaceuticals, a biotech company developing disease-modifying biologics to transform the therapeutic paradigm of specific autoimmune conditions by re-establishing stem cell capabilities in a non-traditional way, today announced the completion of a €28 million Series A financing round co-led by seed investor Sofinnova Partners, and incoming investor ...

Enthera Pharmaceuticals adds Margarita Chavez to its Board along with raising €28m Series A financing co-led by Sofinnova Partners and AbbVie Ventures

Enthera Pharmaceuticals adds Margarita Chavez to its Board along with raising €28m Series A financing co-led by Sofinnova Partners and AbbVie Ventures

From:: Enthera Pharmaceuticals adds Margarita Chavez to its Board along with raising €28m Series A financing co-led by Sofinnova Partners and AbbVie Ventures

Sorry, the comment form is closed at this time.